Quadrature Capital Ltd Lowers Holdings in Oscar Health, Inc. (NYSE:OSCR)

Quadrature Capital Ltd decreased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 55.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,159 shares of the company's stock after selling 48,062 shares during the period. Quadrature Capital Ltd's holdings in Oscar Health were worth $831,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Versor Investments LP purchased a new position in Oscar Health during the third quarter valued at approximately $787,000. Janney Montgomery Scott LLC bought a new stake in shares of Oscar Health during the 3rd quarter valued at $988,000. Algert Global LLC lifted its stake in shares of Oscar Health by 63.3% during the 3rd quarter. Algert Global LLC now owns 369,685 shares of the company's stock valued at $7,841,000 after buying an additional 143,346 shares in the last quarter. Point72 Asset Management L.P. boosted its holdings in Oscar Health by 30.3% in the 3rd quarter. Point72 Asset Management L.P. now owns 1,212,096 shares of the company's stock worth $25,709,000 after buying an additional 281,858 shares during the period. Finally, Parkman Healthcare Partners LLC purchased a new stake in Oscar Health in the 3rd quarter worth $5,302,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of NYSE OSCR traded down $0.79 during mid-day trading on Friday, hitting $15.61. 5,744,764 shares of the company's stock traded hands, compared to its average volume of 5,015,905. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a 1 year low of $7.50 and a 1 year high of $23.79. The company's 50-day moving average is $16.90 and its two-hundred day moving average is $17.84. The company has a market capitalization of $3.86 billion, a P/E ratio of -260.12 and a beta of 1.63.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analysts' expectations of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company's revenue for the quarter was up 68.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.29) earnings per share. On average, equities analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Analysts Set New Price Targets

OSCR has been the subject of a number of recent analyst reports. Piper Sandler reaffirmed an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 price target for the company. Finally, Bank of America cut shares of Oscar Health from a "neutral" rating to an "underperform" rating and reduced their price objective for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $22.93.

Insider Buying and Selling

In other Oscar Health news, COO Steven Wolin sold 19,580 shares of the company's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $354,006.40. Following the transaction, the chief operating officer now owns 102,598 shares of the company's stock, valued at $1,854,971.84. This represents a 16.03 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the sale, the director now owns 89,512 shares in the company, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.